Navigating the therapeutic landscape of SGLT2 inhibitors in diabetes management: exploring efficacy and emerging concerns

• Váldodahkkit: Farazul Hoda (Dahkki), Harsha Negi (Dahkki), Digvijaya Saini (Dahkki), Mawrah Arshad (Dahkki), Sidra Zayed (Dahkki), Mukesh Kumar Raut (Dahkki), Mohammad Anwar Habib (Dahkki), Mohd Akhtar (Dahkki), Abul Kalam Najmi (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Open Exploration Publishing Inc., 2024-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are integral to diabetes treatment, facilitating renal glucose excretion and offering benefits in cardiovascular risk reduction, kidney function preservation, and weight management. However, their integration into diabetes care presents challenges du...